company background image

Bausch + Lomb NYSE:BLCO Stock Report

Last Price


Market Cap







08 Dec, 2022


Company Financials +
BLCO fundamental analysis
Snowflake Score
Future Growth3/6
Past Performance2/6
Financial Health2/6

BLCO Stock Overview

Bausch + Lomb Corporation operates as an eye health company worldwide.


Trading at 38.5% below our estimate of its fair value

Earnings are forecast to grow 36.18% per year

Became profitable this year

Risk Analysis

No risks detected for BLCO from our risk checks.

Bausch + Lomb Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bausch + Lomb
Historical stock prices
Current Share PriceUS$15.25
52 Week HighUS$20.20
52 Week LowUS$12.20
1 Month Change7.55%
3 Month Change-11.18%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-23.75%

Recent News & Updates

Bausch + Lomb: A Solid Play In Challenging Economic Times

Nov 09

Bausch + Lomb reports Q3 mixed earnings; narrows FY22 guidance range

Nov 02

Recent updates

Shareholder Returns

BLCOUS Medical EquipmentUS Market

Return vs Industry: Insufficient data to determine how BLCO performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how BLCO performed against the US Market.

Price Volatility

Is BLCO's price volatile compared to industry and market?
BLCO volatility
BLCO Average Weekly Movement6.5%
Medical Equipment Industry Average Movement8.9%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: BLCO is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: BLCO's weekly volatility (6%) has been stable over the past year.

About the Company

185312,800Joe Papa

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye.

Bausch + Lomb Corporation Fundamentals Summary

How do Bausch + Lomb's earnings and revenue compare to its market cap?
BLCO fundamental statistics
Market CapUS$5.34b
Earnings (TTM)US$58.00m
Revenue (TTM)US$3.77b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BLCO income statement (TTM)
Cost of RevenueUS$1.50b
Gross ProfitUS$2.27b
Other ExpensesUS$2.21b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date


Earnings per share (EPS)0.17
Gross Margin60.19%
Net Profit Margin1.54%
Debt/Equity Ratio35.9%

How did BLCO perform over the long term?

See historical performance and comparison